ByDaniella Gray
Newsweek is a Trust Project member
See more of our trusted coverage when you search.to see more of our trusted coverage when you search.
A ketogenic diet—popularized for weight loss, blood sugar control and other potential health benefits—may increase the risk of certain intestinal cancers, according to new research
The study, led by researchers at the Massachusetts Institute of Technology (MIT) and published in Nature, found that a high-fat, low-carbohydrate ketogenic diet promoted the growth of tumors in the small intestine of mice that were genetically predisposed to developing intestinal cancer
The findings raise fresh questions about how the increasingly popular diet may affect cancer risk in different parts of the digestive system
…
Ketogenic diets work by drastically reducing carbohydrate intake, forcing the body to burn fat for fuel instead of glucose
This <a href="https://healthylife7.com/obesity-and-metabolic-multimorbidity-burden-reveal-hidden-health-risks/” title=”Obesity and Metabolic Multimorbidity Burden Reveal Hidden Health Risks”>metabolic state, known as ketosis, leads to the production of molecules called ketone bodies
The diet was originally developed to treat epilepsy but has since been widely adopted for weight loss and other health goals
The ketogenic diet has become one of America’s most popular eating plans, with an International Food Information Council survey finding that 7 percent of U.S. adults were following the diet in 2022
Researchers noted that previous studies had suggested ketogenic diets might help protect against colon cancer. However, the new investigation found a very different effect in the small intestine
To investigate, the team fed cancer-prone mice a ketogenic diet, a standard control diet or a high-fat, high-calorie diet
They discovered that animals on the ketogenic diet developed more small-intestinal tumors than those on the other diets
Further experiments revealed that this effect was driven not by ketone bodies themselves, but by the large quantities of dietary fat consumed as part of the ketogenic regimen
The researchers found that lipids from the diet activated a cellular signaling pathway known as PPAR-delta, which enhanced the activity of intestinal stem cells
These cells are responsible for continuously renewing the gut lining, but when mutations occur they can also serve as the starting point for tumors
According to the study authors, the results highlight how dietary interventions can affect different tissues in very different ways
Importantly, the findings were observed in mice genetically susceptible to intestinal cancer, not in healthy humans. The researchers cautioned that more work is needed to determine whether the same mechanisms occur in people and whether particular groups may be more vulnerable than others
Even so, the study adds to a growing body of research showing that the relationship between diet and cancer is complex
While ketogenic diets have been investigated as potential treatments for certain diseases and may offer metabolic benefits for some individuals, the new findings suggest that their effects are unlikely to be universally beneficial
The researchers say future studies will be needed to better understand how specific dietary fats influence cancer risk and whether modifying the composition of ketogenic diets could reduce potential harms while preserving any health benefits
Reference
Shay, J.E.S., Chi, F., Constantine N, T., Han, S., Zhang, X., Ten Hoeve, J., Williams, K.J., Seda, N., Sever, T., Fuentes, I., Bhatia, S.N., Calibasi-Kocal, G., Vander Heiden, M.G., Shalek, A.K. and Yilmaz, Ö.H. (2026). Ketogenic diet mediates intestinal tumorigenesis through lipids not ketones. Nature, [online] pp.1–10. doi:10.1038/s41586-026-10779-y
Contact Newsweek editors on this story: Kara Dolman and Emma Lee-Sang
Request Reprint & Licensing
View Editorial & AI Guidelines
